• 1300 Division Rd, Suite 102, West Warwick, RI 02893
  • +1-401-381-0600
  • operations@bca.coop
CAR-T-jpeg-690x591
  • Events, Industry News, Newest Therapies, Organizations

Challenges and Future Opportunities for CAR-T

  • West Warwick, RI
An interview of Dr. Michael Tees and Dr. Fred Locke offering clinician views on CAR-T

A great interview of Dr. Michael Tees and Dr. Fred Locke by Arsalan Arif offering clinician views on current challenges and future opportunities for CAR-T (autologous + allogeneic).

Link to video:  https://carttogether.com

Our takeaways? (1) There’s a move toward outpatient care and (2) unnecessary apheresis bottlenecks are still a thing. There is no good reason for apheresis to be a bottleneck in the delivery of a CAR-T cell therapy to every patient that needs one.

Every member of Blood Centers of America across 43 US states is keen to do everything in their power to ensure apheresis options exist so that safe, on-demand, and cost-effective apheresis collections can happen wherever they are needed, whenever they are needed.

About Blood Centers of America

 Blood Centers of America (BCA) is a member-owned organization comprised of over 50 independent blood centers throughout the North America, representing nearly 40% of the U.S. blood supply. Along with their core business of providing a substantial portion of U.S. blood supply, other BCA member services include patient blood management, transfusion services, immunohematology testing, therapeutic apheresis and tissue and cord blood banking. In addition, BCA members provide a variety of human blood products, cells and tissues to the therapeutic, diagnostic and cell therapy industries.

Share the Post:

Related Posts